92 related articles for article (PubMed ID: 7683913)
41. HIV-1 reverse transcriptase: polymerization properties of the p51 homodimer compared to the p66/p51 heterodimer.
Bavand MR; Wagner R; Richmond TJ
Biochemistry; 1993 Oct; 32(40):10543-52. PubMed ID: 7691176
[TBL] [Abstract][Full Text] [Related]
42. 2.2 A resolution structure of the amino-terminal half of HIV-1 reverse transcriptase (fingers and palm subdomains).
Unge T; Knight S; Bhikhabhai R; Lövgren S; Dauter Z; Wilson K; Strandberg B
Structure; 1994 Oct; 2(10):953-61. PubMed ID: 7532533
[TBL] [Abstract][Full Text] [Related]
43. Role of glutamine-151 of human immunodeficiency virus type-1 reverse transcriptase in RNA-directed DNA synthesis.
Kaushik N; Harris D; Rege N; Modak MJ; Yadav PN; Pandey VN
Biochemistry; 1997 Nov; 36(47):14430-8. PubMed ID: 9398161
[TBL] [Abstract][Full Text] [Related]
44. HIV-1 reverse transcriptase shows no specificity for the binding of primer tRNA(Lys3).
Arion D; Harada R; Li X; Wainberg MA; Parniak MA
Biochem Biophys Res Commun; 1996 Aug; 225(3):839-43. PubMed ID: 8780699
[TBL] [Abstract][Full Text] [Related]
45. Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer.
Wang J; Smerdon SJ; Jäger J; Kohlstaedt LA; Rice PA; Friedman JM; Steitz TA
Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7242-6. PubMed ID: 7518928
[TBL] [Abstract][Full Text] [Related]
46. Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease.
Tomasselli AG; Sarcich JL; Barrett LJ; Reardon IM; Howe WJ; Evans DB; Sharma SK; Heinrikson RL
Protein Sci; 1993 Dec; 2(12):2167-76. PubMed ID: 7507754
[TBL] [Abstract][Full Text] [Related]
47. Deoxynucleotide polymerization by HIV-1 reverse transcriptase is terminated by site-specific styrene oxide adducts after translesion synthesis.
Latham GJ; Lloyd RS
J Biol Chem; 1994 Nov; 269(46):28527-30. PubMed ID: 7525577
[TBL] [Abstract][Full Text] [Related]
48. Contribution of the p51 subunit of HIV-1 reverse transcriptase to enzyme processivity.
Huang SC; Smith JR; Moen LK
Biochem Biophys Res Commun; 1992 Apr; 184(2):986-92. PubMed ID: 1374247
[TBL] [Abstract][Full Text] [Related]
49. RNase H cleavage of tRNAPro mediated by M-MuLV and HIV-1 reverse transcriptases.
Smith CM; Potts WB; Smith JS; Roth MJ
Virology; 1997 Mar; 229(2):437-46. PubMed ID: 9126256
[TBL] [Abstract][Full Text] [Related]
50. Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase.
Boyer PL; Ferris AL; Clark P; Whitmer J; Frank P; Tantillo C; Arnold E; Hughes SH
J Mol Biol; 1994 Oct; 243(3):472-83. PubMed ID: 7525967
[TBL] [Abstract][Full Text] [Related]
51. Two step binding of HIV-1 reverse transcriptase to nucleic acid substrates.
Kruhøffer M; Urbanke C; Grosse F
Nucleic Acids Res; 1993 Aug; 21(17):3943-9. PubMed ID: 7690470
[TBL] [Abstract][Full Text] [Related]
52. Divalent cation modulation of the ribonuclease functions of human immunodeficiency virus reverse transcriptase.
Cirino NM; Cameron CE; Smith JS; Rausch JW; Roth MJ; Benkovic SJ; Le Grice SF
Biochemistry; 1995 Aug; 34(31):9936-43. PubMed ID: 7543283
[TBL] [Abstract][Full Text] [Related]
53. Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.
Peletskaya EN; Kogon AA; Tuske S; Arnold E; Hughes SH
J Virol; 2004 Apr; 78(7):3387-97. PubMed ID: 15016861
[TBL] [Abstract][Full Text] [Related]
54. Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers.
Held DM; Kissel JD; Thacker SJ; Michalowski D; Saran D; Ji J; Hardy RW; Rossi JJ; Burke DH
J Virol; 2007 May; 81(10):5375-84. PubMed ID: 17329328
[TBL] [Abstract][Full Text] [Related]
55. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
[TBL] [Abstract][Full Text] [Related]
56. A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site.
Wu JC; Warren TC; Adams J; Proudfoot J; Skiles J; Raghavan P; Perry C; Potocki I; Farina PR; Grob PM
Biochemistry; 1991 Feb; 30(8):2022-6. PubMed ID: 1705436
[TBL] [Abstract][Full Text] [Related]
57. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation.
Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK
Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945
[TBL] [Abstract][Full Text] [Related]
58. Structure-activity analyses of HIV-1 reverse transcriptase.
Basu A; Basu S; Modak MJ
Biochem Biophys Res Commun; 1992 Mar; 183(3):1131-8. PubMed ID: 1373608
[TBL] [Abstract][Full Text] [Related]
59. RNase D, a reported new activity associated with HIV-1 reverse transcriptase, displays the same cleavage specificity as Escherichia coli RNase III.
Hostomsky Z; Hudson GO; Rahmati S; Hostomska Z
Nucleic Acids Res; 1992 Nov; 20(21):5819-24. PubMed ID: 1280810
[TBL] [Abstract][Full Text] [Related]
60. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro.
Ji X; Klarmann GJ; Preston BD
Biochemistry; 1996 Jan; 35(1):132-43. PubMed ID: 8555166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
